Inactive Instrument

3SBio Inc. (ADR) Stock price Nasdaq

Equities

US88575Y1055

Pharmaceuticals

End-of-day quote Nasdaq
- USD 0.00% Intraday chart for 3SBio Inc. (ADR)
Sales 2023 7.82B 1.08B Sales 2024 * 8.65B 1.2B Capitalization 13.23B 1.83B
Net income 2023 1.55B 215M Net income 2024 * 1.93B 268M EV / Sales 2023 2.1 x
Net Debt 2023 * 800M 111M Net Debt 2024 * 1.76B 243M EV / Sales 2024 * 1.73 x
P/E ratio 2023
11 x
P/E ratio 2024 *
7.26 x
Employees -
Yield 2023 *
2.91%
Yield 2024 *
3.98%
Free-Float 73.96%
More Fundamentals * Assessed data
Managers TitleAgeSince
Chief Executive Officer 61 92-12-31
Director of Finance/CFO - 23-07-02
Director/Board Member 54 12-06-10
Members of the board TitleAgeSince
Director/Board Member 63 92-12-31
Chief Executive Officer 61 92-12-31
Director/Board Member 54 12-06-10
More insiders
3SBio Inc. is an investment holding company mainly engaged in the the development, production, marketing and sale of pharmaceutical products. The Company's main products include recombinant human thrombopoietin (rhTPO) products, tumor necrosis factor (TNF)?inhibitor products and recombinant human erythropoietin (rhEPO) products. The products are sold under the name of TPIAO, Yisaipu, EPIAO and SEPO. The Company distributes its products within the domestic market and to overseas markets, including Sri Lanka, Dominican Republic and Thailand. The Company's subsidiaries include Collected Mind Limited, Hongkong Sansheng Medical Limited and Shenyang Sunshine Pharmaceutical Co., Ltd.. Through its subsidiaries, the Company is engaged in project management and consultation.
More about the company
  1. Stock
  2. Equities
  3. Stock 3SBio Inc.
  4. Stock 3SBio Inc. (ADR) - Nasdaq